Eli Lilly (LLY) PT Lowered to $825 at Wolfe Research
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,244.40 -2.81%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Wolfe Research analyst Alexandria Hammond lowered the price target on Eli Lilly (NYSE: LLY) to $825.00 (from $1,100.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
- Infleqtion, Inc (INFQ) PT Raised to $22 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
